)
)
)
Ainnocence
Ainnocence is a global biotech company leading generative AI–driven therapeutic discovery, built on industry-grade, sequence-based patented proprietary technology and founders 16+ years of domain expertise and training data.
Problem to Solve: Conventional drug discovery relies on costly wet-lab screening, expensive structural biology, and unreliable 3D modeling that fails to translate into experimental success.
Ainnocence Solution: A radical, outcome-first AI discovery system delivering unprecedented speed, massive virtual throughput, and dramatically higher experimental hit rates—across all target classes.
Platform Philosophy: Outcome-First AI
- Scale beyond human intuition:Screens 10⁹–10¹⁰ candidates in hours, versus 10⁶–10⁷ over days or weeks in conventional workflows.
- Structure-agnostic intelligence:
- Does not require solved protein structures; performs robustly on flexible, disordered, or unknown targets where docking fails.
Ainnocence White Paper by C&EN
Ainnocence Press Release
Address
Mountain ViewCalifornia
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)